Man Group
ATXS

Man Group’s Astria Therapeutics ATXS Stock Holding History

Man Group’s Portfolio ATXS Stock Details ATXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-977,202
Closed -$12.8M – 2384
2025
Q4 		$12.8M Buy
+977,202
New +$11.7M 0.02% 676
2023
Q1 		– Hold
0
– – – 1841

Man Group's ATXS Position: Q1 2026 in Review

Man Group sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 977,202 shares — an estimated $12.8M sold.

Man Group first reported a position in ATXS in Q4 2025 and held it in 1 quarter. The position peaked at $12.8M in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

  • Man Group reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Man Group sold 977,202 Astria Therapeutics shares in Q1 2026, an estimated $12.8M.
  • Man Group first reported a position in Astria Therapeutics in Q4 2025 and held it in 1 quarter.
  • Man Group's Astria Therapeutics position peaked at $12.8M in Q4 2025.
  • 0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.